The European Medicines Agency (EMA) announced today that it has begun evaluating the use of the Moderna vaccine against Covid-19 in children aged six months to 5 years, the last age group that cannot yet be vaccinated.
“We have just begun evaluating a request from Moderna to extend the use of Spikevax to children aged six months to 5 years and it is the first request for this new age group,” Marco Cavaleri, head of the department, told a news conference. strategy for EMA vaccines.
The American biotechnology company Moderna already made a similar request in the US last week after tests showed that these vaccines are safe and produce a strong immune response.
Young children are less vulnerable to the virus than older people, but they can still get sick and transmit the virus.
Severe forms of multisystem inflammatory bowel syndrome (MIS-C) can also occur in children.
Coreper approved in February the use of the Moderna Covid vaccine for children aged six and over in the 27 member states of the European Union.
Source: ΑΠΕ-ΜΠΕ
Source: Capital
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
